BioSpace News Archive

NanoVibronix, Inc., (NASDAQ: NAOV) today provided a response to the recently published payment determination by the Centers for Medicare & Medicaid Services (“CMS”) regarding the company’s PainShield device.

Amit Zeisel, PhD and Ido Solt, MD and their research team at the Technion – Israel Institute of Technology and Rambam Hospital, together with Prof. Simcha Yagel, MD of Hadassa Hospital, have published new research that provides systematic molecular evidence for two disease pathways for preeclampsia, a life-threatening hypertensive disorder of pregnancy.

Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) (“Britannia” or the “Company”) is pleased to provide its unaudited financial results for the three months ended June 30, 2023. These filings and additional information regarding Britannia are available for review on SEDAR at www.sedar.com.

TwinStrand Biosciences®, the pioneer in Duplex Sequencing technology, which delivers accurate insights to researchers in applications ranging from residual cancer detection to genetic toxicology announced the appointment of Ron Andrews, as Chief Executive Officer and Board Member.

Akadeum Life Sciences, the global leaders in buoyancy-based cell separation technology, have today announced the release of their ‘Human T Cell Activation & Expansion Kit’ with Buoyancy Activated Cell Sorting (BACS) microbubbles.

CobiCure Medical Technologies announced today its continued commitment to solving the unmet needs in pediatric medical technologies with a grant of strategic support, resources, and $2 million in funding to PolyVascular, a Houston,TX based medical device company, developing a transformative, first of its kind, non-surgical heart valve for young children suffering from congenital heart disease.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) today announced that its Chief Executive Officer Jon Congleton, and Chief Financial Officer and Chief Business Officer, Adam Levy, will participate in a fireside chat at the Wells Fargo Securities Healthcare Conference in Boston, Massachusetts on Thursday, September 7, 2023 at 8:45 a.m. ET.

Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) – a commercial-stage medical technology company – today reported financial results for its second quarter ended June 30, 2023 and provided a corporate update.

SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Morgan Stanley 21st Annual Global Healthcare Conference in New York.